Latest articles from Medical Marketing and Media

Roundtable outlines path for publisher, pharma credibility

Wed, 23 May 2012 20:19:00 GMT

In an effort to shore up their reputations, pharma and professional publishers have come together to craft an accountability plan.

Did FDA's Vytorin warning negatively impact health outcomes?

Wed, 23 May 2012 19:24:37 GMT

An analysis of the FDA's handling of the Vytorin debacle points to a need for better public-health warnings about medications, researchers say.

No-see docs are know-nothings when it comes to new drug info, study suggests

Tue, 22 May 2012 18:50:06 GMT

An AstraZeneca-sponsored study found that doctors who don't see sales reps are far slower to respond to medical developments such as new products, black box warnings and clinical trials data.

E-prescriptions boost adherence data

Tue, 22 May 2012 16:22:53 GMT

A new study by Surescripts, the nation's largest e-prescription network, suggests that saving patients the trouble of toting a prescription to a store increases the likelihood that they will get it filled and take their meds.

How CDC's hep.-C testing advice benefits drugmakers now

Tue, 22 May 2012 15:52:22 GMT

The CDC's proposal that all US baby boomers get a one-time test for the hepatitis C virus has already given a boost to drugmakers in the antiviral space.

PhRMA's Washington wish list

Mon, 21 May 2012 20:10:33 GMT

PhRMA presented Washington with its legislative wish list - and a warning that plenty of other countries are trying to woo the industry away from the US.

Study: Young Latinas are key decision makers, prefer English

Mon, 21 May 2012 19:33:32 GMT

Effectively communicating health messages to the Hispanic community requires one key thing: reaching Latinas between the ages of 25 and 35.

Pharmas are from Mars, Payers are from Venus

Thu, 17 May 2012 19:17:06 GMT

Pharma needs to step up its sales pitch, looking beyond a drug's top attributes, to convince payers that their drugs are worth the cost.

Goodbye Plavix, hello competition

Thu, 17 May 2012 15:45:53 GMT

Long-running blockbuster Plavix has joined the patent graveyard, and competitors are all in.

Indian conglomerate buys Manhattan Research parent for $635m

Wed, 16 May 2012 19:13:55 GMT

A Mumbai-based pharma custom manufacturing firm is buying the parent company of Manhattan Research.

Headliner: Hayes' open-door policy opens doors

Tue, 01 May 2012 04:00:00 GMT

Tim Hayes, President, Bayer HealthCare Consumer Care North America

Med Ed Report: Show Me the Money

Tue, 01 May 2012 04:00:00 GMT

Following industry's CME cutback, dinner meetings and other kinds of peer-to-peer interaction are grabbing more of its meeting spend. How much more, and is this good for medical education? David Rear reports

MM&M Awards: Dream Team 2012

Tue, 01 May 2012 04:00:00 GMT

This year's judges for the MM&M Awards once again represent the cream of the industry's leaders and thinkers. But this year, there are twice as many of them. Find out who made it onto the panel

Pharma Report 2012: Get Back in Shape

Tue, 01 May 2012 04:00:00 GMT

When big pharma looks in the mirror, what does it see? A body beset by old, expiring brands and not enough energetic, youthful ones to replace them. Marc Iskowitz has industry's regimen for regaining form

Product Communications: When Love Is Blind

Tue, 01 May 2012 04:00:00 GMT

Getting too enamored of products can lead to losing sight of customer needs. Fred Kinch on how to avoid being blinded by product devotion